Enzymotec Settles IPO Stock-Drop Suit For $6.5M
Israeli biotech company Enzymotec Ltd. and a putative class of shareholders have reached a $6.5 million settlement and asked a New Jersey federal judge on Friday to recognize the class and...To view the full article, register now.
Already a subscriber? Click here to view full article